ESC Premium Access

How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?


Congress Presentation

About the speaker

Professor Pieter Kamphuisen

Tergooi MC, Hilversum (Netherlands (The))
1 presentation
0 follower

2 more presentations in this session

Bleeding risk as one of major hurdles in stroke prevention therapy prescription.

Speaker: Professor C. Granger (Durham, US)


Novel biomarker-based risk scores for better stratification of stroke and major bleeding risk in AF patients and OAC therapy optimization.

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)


Access the full session

Biomarker-based approaches for improved atrial fibrillation management

Speakers: Professor P. Kamphuisen, Professor C. Granger, Associate Professor Z. Hijazi

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb